Image Ben Hargreaves Patients Power to the patients: Patient organisations enabling drug d... Drug development is a complex process and there are many stakeholders involved in bringing treatments to patients. Patients Action by FDA ensures trial sponsors must consider diversity Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change. Market Access How the pandemic exposed faulty links in the supply chain The pandemic provided a harsh shock to healthcare, but proved particularly tough on the supply chains relied on to support public health. Patients Healthcare report finds declining public trust in institutio... There are few things more important than health, but a recent report suggests that the public has declining trust in traditional healthcare institutions to protect theirs. Load more results
Patients Power to the patients: Patient organisations enabling drug d... Drug development is a complex process and there are many stakeholders involved in bringing treatments to patients.
Patients Action by FDA ensures trial sponsors must consider diversity Pharma has recognised that there is a problem with diversity in clinical trials, but has so far struggled to successfully achieve real change.
Market Access How the pandemic exposed faulty links in the supply chain The pandemic provided a harsh shock to healthcare, but proved particularly tough on the supply chains relied on to support public health.
Patients Healthcare report finds declining public trust in institutio... There are few things more important than health, but a recent report suggests that the public has declining trust in traditional healthcare institutions to protect theirs.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
